Supraventricular Tachycardia - PowerPoint PPT Presentation

About This Presentation
Title:

Supraventricular Tachycardia

Description:

Thought to be due to a hyperadrenergic state and CCB and helpful. Atrial Fibrillation Control the rate using IV calcium channel blockers or beta-blockers ... – PowerPoint PPT presentation

Number of Views:508
Avg rating:3.0/5.0
Slides: 40
Provided by: phdresCar
Category:

less

Transcript and Presenter's Notes

Title: Supraventricular Tachycardia


1
Supraventricular Tachycardia
  • Teresa Menendez Hood, MD FACC
  • Presbyterian Hospital of Dallas

2
Supraventricular Tachycardias
  • AV nodal reentry tachycardia
  • AV reentry tachycardia - the WPW(Wolff-Parkinson
    White) Syndrome
  • Atrial flutter
  • Atrial Fibrillation
  • Atrial Tachycardia
  • Sinus Tachycardia and Sinus Node Reentry

3
Atrial Fibrillation
  • Unorganized, very rapid electrical foci in the
    atria
  • No contraction of the atria as a whole
  • In order to protect the ventricles, the AV node
    blocks most of the atrial impulses from
    conducting through to the ventricles, thus
    protecting the ventricles
  • Controlled rate ventricular rate lt 100
    beats/min
  • Uncontrolled rate ventricular rate gt 100
    beats/min

4
Atrial Fibrillation
  • Characteristics of atrial fibrillation
  • Ventricular rhythm is usually irregularly
    irregular
  • Average ventricular rate is 160 180 beats/min
    on no drugs
  • No P waves seen
  • QRS interval is usually normal (narrow)
  • If see discrete P wavesthink of MAT
  • This clinical scenario is a cardiac or pulmonary
    patient in the ICU. Thought to be due to a
    hyperadrenergic state and CCB and helpful.

5
Atrial Fibrillation
  • Control the rate using IV calcium channel
    blockers or beta-blockersIV dig does not work
  • If the A-fib is chronic (gt 48 hours)
  • Chemical cardioversion after a period of
    anticoagulation
  • Electrical cardioversion only after
    anticoagulation

6
Atrial fibrillation accounts for 1/3 of all
patient discharges with arrhythmia as principal
diagnosis.
6 PSVT
6 PVCs
18 Unspecified
4 Atrial Flutter
9 SSS
34 Atrial Fibrillation
8 Conduction Disease
10 VT
3 SCD
2 VF
Data source Baily D. J Am Coll Cardiol.
199219(3)41A.
7
Classification of Atrial FibrillationThe 3 Ps
  • Permanent - Conversion to sinus rhythm not
    possible
  • Persistent - Capable of being converted to sinus
    rhythm
  • Paroxysmal - Converts spontaneously to sinus
    rhythm

Gallagher MM and Camm AJ Clin Cardiol 199720381
8
AF Anticoagulation - General Points
  • AF most common significant rhythm disorder
  • Prevalence 1.5-3 of patients in their
    60s 5-7 of patients in their 70s 15 of
    patients in their 80s
  • AF most potent common risk factor for stroke
  • Relative risk 5
  • Patients with AF can be stratified according to
    risk of stroke

Feinberg WM e al. Arch Intern Med 1995155469
Wolf PA et al. Stroke199122983
9
AF Anticoagulation - General Points
  • Anticoagulation (INR 2.0 - 3.0) can reduce risk
    of stroke by 2/3 1,2
  • Aspirin has little effect on risk of stroke due
    to AF 3

1 Hylek EM and Singer DE. Arch Intern Med
1994120897 2 Hylek EM et al. New Engl J Med
1966335540 3 The Atrial Fibrillation
Investigators. Arch Intern Med 19971571237
10
Risk Factors for Stroke in AF
  • Risk Factor
  • Prior stroke
  • Age
  • Hypertension
  • Diabetes
  • Relative Risk (multivariate)
  • 2.5
  • 1.4 (per decade)
  • 1.6
  • 1.7

Absolute Risk Age lt 65 years and no risk factors,
lone AF ?1/yr. All others 3.5-8/yr
lowered to 1.5/yr by warfarin
The Atrial Fibrillation Investigators Arch
Intern Med 19941541449
11
Elective Cardioversion of AFAnticoagulation
  • Cardioversion appears to raise risk of embolism
  • 1-5 emboli within hours to weeks
  • Anticoagulation well before and after greatly
    reduces risk
  • Standard guideline for electrical or drug
    cardioversion
  • INR 2 - 3 for 3 weeks before and
  • INR 2 - 3 for 4 weeks after NSR
  • IF AF lt 2 days duration, no anticoagulation

Laupacle A et al. Chest 1995108 Prystowsky EN et
al. Circulation 19961262
12
Adequate Rate Control
  • At office visits
  • Apical (not radial) heart rate (sitting) ? 80 /
    min
  • On 24-hour Holter monitor
  • Goal average hourly heart rate ? 80 / min
  • Exercise testing
  • Inadequate ? 85 age-predicated maximum heart
    rate in stage I (Bruce) or 3 min of exercise
  • Digoxin alone will never control the rate unless
    the patient has intrinsic AVN conduction system
    disease

13
Tachycardia - Induced Cardiomyopathy
  • Chronic tachycardia in otherwise structurally
    normal heart as the sole cause of developing
    ventricular dysfunction
  • Can follow any chronic cardiac tachyarrhythmia

Fenelon G et al. Pacing Clinical Electrophysiol
19961995
14
Preference for Acute Cardioversion
  • DC Cardioversion
  • i.v. Ibutilide
  • Other
  • Oral Flecainide
  • Oral Propafenone
  • i.v. Procainamide

15
Preference for Acute Cardioversioni.v. Ibutilide
  • QTc ? 460 msec
  • Short duration of AF (lt30 days)
  • No clinical CHF. K and Mg levels OK
  • Anesthesia risk (e.g., COPD)
  • Patient preference
  • Acute efficacy - flutter (63), fib (31)
  • Caution risk of polymorphic VT (8)

Stambler BS, et al. Circulation 1996 941613-1621
16
Long term treatment
  • Beyond the scope of this talk
  • Guided by patient symptoms
  • AFFIRM trial did not show any benefit of NORMAL
    SINUS RHYTHM versus AFIB with rate control in
    patients who had minimal symptoms
  • Ablation for AFIB is guided by patients symptoms
    and drug failures

17
Atrial Flutter
  • Usually a single, irritable foci in the atria
    (right)
  • AV node protects the ventricles by blocking some
    of the atrial impulses (decremental conduction)
  • P waves take on a sawtooth appearance and are
    called F waves or flutter waves
  • Atrial rhythm and ventricular response are
    usually regular
  • Atrial rate 250-350 beats/min. Ventricular rate
    varies depending on the number of impulses the AV
    node is blocking
  • No P waves or PR interval
  • QRS normal width or with aberrancy

18
Atrial Flutter
  • Treatment
  • Same as atrial fibrillation but often harder to
    slow the ventricular rate
  • Long term treatment is ablation and NOT drugs!

19
RF Ablation of Atrial Flutter
  • Atrial flutter involves a macro-reentry circuit
    within the right atrium.
  • Critical areas of conduction within the right
    atrium are necessary to sustain atrial flutter.
  • RF ablation of conduction within such critical
    sites (most commonly the inferior vena
    cava-tricuspid valve isthmus) abolishes atrial
    flutter in 85 of cases.

Cosio FG. Am J Cardiol. 199371705-709.
20
Diagram of Atrial Flutter Circuit Within Right
Atrium
Inferior vena cava - tricuspid valve isthmus
Cosio FG. Am J Cardiol. 199371705-709.
21
Differential Diagnosis ofWide-Complex Tachycardia
  • VT
  • SVT with aberrancy (atrial fibrillation/flutter)-i
    .e. BB Block
  • Antidromic AV reentry i.e. antegrade via WPW
    accessory pathway
  • Atrial fibrillation, atrial flutter, atrial
    tachycardia, or AV nodal reentry in setting of
    WPW with rapid conduction down accessory pathway
    that is activated as a bystander-I.e. not an
    integral part of the circuit.

22
Narrow QRS
Wide QRS - BBB(Aberrant conduction)
AVN
A
B
HB
RB
LB
Wide QRS - VT
Wide QRS - Preexcitation(Conduction via AP)
C
D
Akhtar M. InZipes and Jalife. Cardiac
Electrophysiology from Cell to Bedside. 1990636.
23
Key ECG Signs
  • Atrial activity
  • QRS configuration
  • R-R cycle length
  • Aberrant ventricular conduction
  • Response to vagal maneuvers

24
An EKG you will see on the Boards..
  • This has been on every Board exam I have ever
    taken. Please do give AVN blockers for this!When
    in doubt, treat as if you thought this was VT.

25
Atrial Fibrillation with Preexcitation
26
Electrocardiographic Differentiation of VT vs.
SVT with Aberrancy
  • Clinical history if the patient has had an MI
    in the past?it is VT until proven otherwise
  • AV dissociation
  • QRS morphology
  • QRS axis
  • Fusion beat
  • Capture beat

27
A-V Dissociation, Fusion, and Capture Beats in VT
V1
E
F
C
ECTOPY
FUSION
CAPTURE
Fisch C. Electrocardiography of Arrhythmias.
1990134.
28
ECG Distinction of VT from SVT with Aberrancy
  • Favors VT Favors SVT with Aberrancy

Duration RBBB QRS gt 0.14 sec. lt 0.14
sec. LBBB QRS gt 0.16 sec. lt 0.16 sec. Axis QRS
axis -90 to 180 Normal
29
ECG Distinction of VT from SVT with Aberrancy
  • Favors VT Favors SVT with Aberrancy

Morphology Precordial concordance If LBBB V1
duration gt 30 ms S wave gt 70 ms S wave notched
or slurred V6 qR or QR R wave If
RBBB V1 monophasic R wave qR If triphasic,
R gt R1 R lt R1 V6 R lt S
30
Sinus Tachycardia
  • Sinus node is still the pacemaker, but the rate
    is accelerated for some physiologic reason
  • Rhythm is regular
  • Rate gt 100 beats/minute
  • P wave, PR interval, and QRS complex are all
    normal
  • Can look like Sinus Node Reentry paroxysmal and
    less than 160 BPM incidence of 10 of all PSVTs

31
Sinus Tachycardia
  • Treatment
  • Alleviate the underlying cause-anemia, pheo,
    hyperthyroid
  • Could be inappropriate ST- a type of autonomic
    dysfunction with HR consistently above 120

32
Paroxysmal Supraventricular Tachycardia
  • Repeated episodes of tachycardia with an abrupt
    onset and ending (paroxysmal)
  • SVT is usually due to a reentry mechanism.
  • Could also be to abnormal automaticity or
    triggered activity but would have more of a
    warm-up and cool-down effect.

33
Supraventricular Tachycardia
  • Characteristics
  • Rhythm is regular
  • Rate 140-220 beats/minute
  • P waves may be buried in the QRS or the T wave
    and may differ in morphology from sinus P waves
  • PR and QRS interval may be normal or prolonged.

34
Supraventricular Tachycardia
  • Long term treatment is with ablation in most
    cases
  • Response to vagal maneuvers is helpful
  • Acutely meds used to decrease the rate or
    convert the patient to NORMAL SINUS RHYTHM
    Adenosine, IV Verapamil or Esmolol
  • If patient is unstable
  • Electrical cardioversion

35
Pearls
  • ST depression is common during SVT and is not a
    marker of serious ischemia
  • If the first dose of Adenosine does not work?
    Then add 6mg to the amount and give again
    (6-12-18)do not repeat the same dose. (If given
    via central line then 3-6-9-12)
  • Adenosine may put the patient in AFBbe ready to
    cardiovert.

36
Classification of PSVT
  • Short R-P
  • AVRT(slow-fast)
  • AVNRT
  • Long R-P
  • Atypical forms of the AVNRT (fast-slow)or
    AVRT(usually will have a negative P wave in
    2,3,avf)
  • Most atrial tachycardias, SNRT
  • PJRT

37
Atrial Tachycardia
  • Reentry, Automaticity and Triggered (rare)
    Activity have been found as causes
  • Rates 120 to 150
  • Usually 11 AVN conduction and persistence
    despite AV block
  • Usually from right atria (Ring of Fire)
  • Can be seen as an incisional tachycardia from
    previous surgery..i.e. ASD repair
  • May see remission in children so do not attempt
    ablation until adulthood.

38
AVN reentry
  • Most common from of PSVT
  • Can occur at any age and more common in women
  • Typical form is down the slow and up the fast
    pathway in the AVN region.
  • Adenosine is the drug on choice for conversion.
    Need to be careful about pts with reactive airway
    disease and those on persantine. It may not work
    in pts with theophylline.

39
WPW
  • Pre-excitation affects 3/1000 patients on routine
    screening.not all develop PSVT
  • Antegrade (delta wave) and retrograde conduction
  • More common in men
  • Most present in young adulthood
  • 15 incidence of AFIB
  • Multiple pathways in 10
Write a Comment
User Comments (0)
About PowerShow.com